One of only about 150 people known to have the rare fatal condition, he traveled internationally to raise awareness and participated in the search for a cure.

Sammy Basso, an advocate for research into progeria, an ultrarare fatal disease that causes rapid aging in children, who was known for living with gusto and humor as he faced the certainty of premature death, died on Oct. 5 near his home in Tezze sul Brenta, in the Veneto region of northern Italy. He was 28.

Dr. Leslie B. Gordon, medical director of the Progeria Research Foundation, for which Mr. Basso served as global ambassador, said the cause was complications of the disease. Mr. Basso had survived longer than any other known person with progeria.

Mr. Basso, who lived with his parents, was diagnosed with progeria at age 2.

He was one of only about 150 people worldwide identified with the condition. He traveled internationally, most recently to China, to raise awareness; gave TED Talks; and participated with scientists from Harvard and the National Institutes of Health in a research group that is seeking a cure.

“You couldn’t watch a presentation by Sammy without being captivated by his courage, his spunk, his smarts and his sense of humor,” Dr. Francis S. Collins, a former N.I.H. director who has long researched progeria, said in an email.

Progeria, also known as Hutchinson-Gilford progeria syndrome, causes children to undergo rapidly accelerated aging; its effects include baldness, wrinkled skin, hardening of the arteries and a wizened stature. Mr. Basso was about 4 feet 5 inches tall and weighed about 44 pounds.

At the same time, individuals with the condition, whose average life expectancy is 14.5 years, do not experience senility.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.


Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.


Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.